NBIX · Neurocrine Biosciences Inc · Congressional Trades
$148.45
+2.45 (+1.68%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$14.84B
Shares
101.65M
Volume · Oct 28
1.09M
Avg daily vol (3M)
1.31M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2025-06-17 | Lisa McClain | Representative | Sell ST · Neurocrine Biosciences, Inc. - Common Stock (NBIX) | SP Charles Schwab Brokerage Account 924 | $1K - $15K | 2025-08-13 | 57d late |
| 2025-06-11 | Lisa McClain | Representative | Buy ST · Neurocrine Biosciences, Inc. - Common Stock (NBIX) | SP Charles Schwab Brokerage Account 924 | $1K - $15K | 2025-08-13 | 63d late |
| 2020-12-21 | Gilbert Cisneros | Representative | Buy ST · Neurocrine biosciences, Inc. (NbIX) | — 150 Main Street Trust > U.S. Trust Holdings | $1K - $15K | 2021-01-11 | 21d |
| 2020-07-21 | Gilbert Cisneros | Representative | Sell ST · Neurocrine biosciences, Inc. (NbIX) | — 150 Main Street Trust > U.S. Trust Holdings | $1K - $15K | 2020-08-19 | 29d |
Showing 1–4 of 4 trades
Key facts
CIK
914475
CUSIP
64125C109
13F (30d)
195 filings
184 filers
Visit website
Investor relations